Israel Sorafenib Market (2025-2031) | Forecast, Size & Revenue, Trends, Outlook, Analysis, Share, Value, Companies, Industry, Segmentation, Growth, Competitive Landscape

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3.1 Israel Country Macro Economic Indicators

3.2 Israel Sorafenib Market Revenues & Volume, 2021 & 2031F

3.3 Israel Sorafenib Market - Industry Life Cycle

3.4 Israel Sorafenib Market - Porter's Five Forces

3.5 Israel Sorafenib Market Revenues & Volume Share, By Type, 2021 & 2031F

3.6 Israel Sorafenib Market Revenues & Volume Share, By Application, 2021 & 2031F

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing incidence of liver cancer in Israel

4.2.2 Growing awareness about the effectiveness of sorafenib in treating liver cancer

4.2.3 Favorable government regulations and policies supporting the use of sorafenib in cancer treatment

4.3 Market Restraints

4.3.1 High cost associated with sorafenib treatment

4.3.2 Presence of alternative treatment options for liver cancer

4.3.3 Potential side effects and limited efficacy of sorafenib in some patients

6.1 Israel Sorafenib Market, By Type

6.1.1 Overview and Analysis

6.1.2 Israel Sorafenib Market Revenues & Volume, By Type, 2021- 2031F

6.1.3 Israel Sorafenib Market Revenues & Volume, By Patented Drugs, 2021- 2031F

6.1.4 Israel Sorafenib Market Revenues & Volume, By Generic Drugs, 2021- 2031F

6.2 Israel Sorafenib Market, By Application

6.2.1 Overview and Analysis

6.2.2 Israel Sorafenib Market Revenues & Volume, By Kidney Cancer, 2021- 2031F

6.2.3 Israel Sorafenib Market Revenues & Volume, By Liver Cancer, 2021- 2031F

6.2.4 Israel Sorafenib Market Revenues & Volume, By Thyroid Cancer, 2021- 2031F

7.1 Israel Sorafenib Market Export to Major Countries

7.2 Israel Sorafenib Market Imports from Major Countries

8.1 Average patient survival rate post sorafenib treatment

8.2 Number of healthcare facilities offering sorafenib treatment

8.3 Rate of adoption of sorafenib in first-line treatment for liver cancer

9.1 Israel Sorafenib Market Opportunity Assessment, By Type, 2021 & 2031F

9.2 Israel Sorafenib Market Opportunity Assessment, By Application, 2021 & 2031F

10.1 Israel Sorafenib Market Revenue Share, By Companies, 2024

10.2 Israel Sorafenib Market Competitive Benchmarking, By Operating and Technical Parameters